| Sumario: | As the FDA continues to approve commercial Chimeric antigen receptor T (CAR- T) cell treatments, there is a growing need for quick access to resources when providing direct care to patients undergoing treatments. Commercial products require strict oversite by the organization to ensure all FDA-required components are met due to the high risk of patient mortality related to the treatment. Having resources available for bedside nurses to assist in early recognition of cytokine release syndrome and/or immune effector cell-associated neurotoxicity syndrome are vital to patient safety. Currently, our program provides five different commercial products that have slightly different interventions based on patient symptom grading. Bedside nurses are tasked with utilizing our SBAR communication process with the on-call provider to ensure early intervention. To provide nursing immediate access to materials, CAR T resources were placed on Microsoft Teams to allow mobile and remote access. Interventions included creating a Teams channel titled CAR T Binder, creating separate folders for commercially approved products, organizing the folders in a standard manner to ensure quick access to needed documents, and maintaining the resources to ensure accuracy for clinical nurses. In evaluating the process, nurses expressed the ease of finding the information on their personnel phones and increased comfort level with knowledge of where to find immediate access to the information. For staff who do not choose to use their phones, they are able to log in to the Teams site on desktop computers and access the information. The resources they have found the most useful are the admission and prior to infusion check list. They can review their prior education materials before caring for the patient. Due to lack of provider access to Teams, the decision was made to keep a hard-bound binder available on the unit for providers to access the grading and treatment guidelines. The quick access to resources was well received by staff. With the addition of new commercial treatments, new folders and materials will be added. The leadership team continues ongoing conversations regarding the Teams channel and suggestions for additional resources needed. As this field continues to expand to multiple different cancer diagnoses with varying treatment guidelines, it is vital to assist clinical nurses in providing quality patient care and ensuring early recognition for patient safety.
|
|---|